236 related articles for article (PubMed ID: 20506116)
1. 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles.
Woeckel VJ; Alves RD; Swagemakers SM; Eijken M; Chiba H; van der Eerden BC; van Leeuwen JP
J Cell Physiol; 2010 Nov; 225(2):593-600. PubMed ID: 20506116
[TBL] [Abstract][Full Text] [Related]
2. Evidence of vitamin D and interferon-β cross-talk in human osteoblasts with 1α,25-dihydroxyvitamin D3 being dominant over interferon-β in stimulating mineralization.
Woeckel VJ; Koedam M; van de Peppel J; Chiba H; van der Eerden BC; van Leeuwen JP
J Cell Physiol; 2012 Sep; 227(9):3258-66. PubMed ID: 22105341
[TBL] [Abstract][Full Text] [Related]
3. 1α,25-dihydroxyvitamin D3 stimulates activin A production to fine-tune osteoblast-induced mineralization.
Woeckel VJ; van der Eerden BC; Schreuders-Koedam M; Eijken M; Van Leeuwen JP
J Cell Physiol; 2013 Nov; 228(11):2167-74. PubMed ID: 23589129
[TBL] [Abstract][Full Text] [Related]
4. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization.
Lynch MP; Stein JL; Stein GS; Lian JB
Exp Cell Res; 1995 Jan; 216(1):35-45. PubMed ID: 7813631
[TBL] [Abstract][Full Text] [Related]
5. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
6. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
Varga F; Spitzer S; Klaushofer K
Calcif Tissue Int; 2004 Apr; 74(4):382-7. PubMed ID: 15255076
[TBL] [Abstract][Full Text] [Related]
7. 1α,25-dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization.
Woeckel VJ; Bruedigam C; Koedam M; Chiba H; van der Eerden BC; van Leeuwen JP
Gene; 2013 Jan; 512(2):438-43. PubMed ID: 22967709
[TBL] [Abstract][Full Text] [Related]
8. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal.
Byers BA; Pavlath GK; Murphy TJ; Karsenty G; García AJ
J Bone Miner Res; 2002 Nov; 17(11):1931-44. PubMed ID: 12412799
[TBL] [Abstract][Full Text] [Related]
9. Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization.
Seriwatanachai D; Krishnamra N; van Leeuwen JP
J Cell Biochem; 2009 Jul; 107(4):677-85. PubMed ID: 19365811
[TBL] [Abstract][Full Text] [Related]
10. TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype.
Breen EC; Ignotz RA; McCabe L; Stein JL; Stein GS; Lian JB
J Cell Physiol; 1994 Aug; 160(2):323-35. PubMed ID: 8040190
[TBL] [Abstract][Full Text] [Related]
11. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling.
Gordeladze JO; Drevon CA; Syversen U; Reseland JE
J Cell Biochem; 2002; 85(4):825-36. PubMed ID: 11968022
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.
Ueno A; Miwa Y; Miyoshi K; Horiguchi T; Inoue H; Ruspita I; Abe K; Yamashita K; Hayashi E; Noma T
J Cell Physiol; 2006 Nov; 209(2):322-32. PubMed ID: 16883596
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
[TBL] [Abstract][Full Text] [Related]
15. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
[TBL] [Abstract][Full Text] [Related]
16. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.
Gordon JA; Tye CE; Sampaio AV; Underhill TM; Hunter GK; Goldberg HA
Bone; 2007 Sep; 41(3):462-73. PubMed ID: 17572166
[TBL] [Abstract][Full Text] [Related]
17. Bone matrix mRNA expression in differentiating fetal bovine osteoblasts.
Ibaraki K; Termine JD; Whitson SW; Young MF
J Bone Miner Res; 1992 Jul; 7(7):743-54. PubMed ID: 1642143
[TBL] [Abstract][Full Text] [Related]
18. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation.
Kwun IS; Cho YE; Lomeda RA; Shin HI; Choi JY; Kang YH; Beattie JH
Bone; 2010 Mar; 46(3):732-41. PubMed ID: 19913120
[TBL] [Abstract][Full Text] [Related]
19. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.
Siggelkow H; Rebenstorff K; Kurre W; Niedhart C; Engel I; Schulz H; Atkinson MJ; Hüfner M
J Cell Biochem; 1999 Oct; 75(1):22-35. PubMed ID: 10462701
[TBL] [Abstract][Full Text] [Related]
20. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
